Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
2966 | 2101 | 32.1 | 69% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
6 | 4 | GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY | 1371034 |
216 | 3 | NON SMALL CELL LUNG CANCER//LUNG CANCER//THORAC SURG | 51214 |
1102 | 2 | PACLITAXEL//TAXANES//EPOTHILONES | 9807 |
2966 | 1 | METASTATIC BREAST CANCER//VINORELBINE//DOCETAXEL | 2101 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | METASTATIC BREAST CANCER | authKW | 2001400 | 22% | 30% | 467 |
2 | VINORELBINE | authKW | 636753 | 10% | 22% | 203 |
3 | DOCETAXEL | authKW | 425526 | 15% | 9% | 322 |
4 | CAPECITABINE | authKW | 394666 | 10% | 13% | 203 |
5 | ADVANCED BREAST CANCER | authKW | 300808 | 5% | 22% | 96 |
6 | ANTHRACYCLINE RESISTANCE | authKW | 154278 | 1% | 56% | 19 |
7 | PACLITAXEL | authKW | 114974 | 10% | 4% | 220 |
8 | SEMINARS IN ONCOLOGY | journal | 109496 | 9% | 4% | 198 |
9 | EPIRUBICIN | authKW | 107495 | 4% | 9% | 83 |
10 | TAXANES | authKW | 104022 | 4% | 8% | 91 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 67494 | 91% | 0% | 1902 |
2 | Pharmacology & Pharmacy | 766 | 13% | 0% | 283 |
3 | Obstetrics & Gynecology | 193 | 4% | 0% | 78 |
4 | Health Care Sciences & Services | 19 | 1% | 0% | 23 |
5 | Dance | 16 | 0% | 0% | 1 |
6 | Medicine, General & Internal | 9 | 3% | 0% | 60 |
7 | Health Policy & Services | 1 | 0% | 0% | 8 |
8 | Medicine, Research & Experimental | 1 | 2% | 0% | 32 |
9 | Film, Radio, Television | 0 | 0% | 0% | 1 |
10 | Medical Ethics | 0 | 0% | 0% | 1 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | NO ALBERTA BREAST CANC PROGRAM | 101724 | 0% | 100% | 7 |
2 | CANC THER Y DEV PROGRAM | 46501 | 0% | 80% | 4 |
3 | BREAST CANC MED SERV | 42589 | 1% | 13% | 22 |
4 | MED ONCOL | 41530 | 17% | 1% | 365 |
5 | BREAST ONCOL GRP | 33212 | 0% | 57% | 4 |
6 | BIOPATHOLU891 | 29064 | 0% | 100% | 2 |
7 | BIOSTATU891 | 29064 | 0% | 100% | 2 |
8 | CLIN ONCOL HEMATOL UNIT | 29064 | 0% | 100% | 2 |
9 | MED ONCOLU891 | 29064 | 0% | 100% | 2 |
10 | OCP TCO | 29064 | 0% | 100% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | SEMINARS IN ONCOLOGY | 109496 | 9% | 4% | 198 |
2 | ANNALS OF ONCOLOGY | 41846 | 7% | 2% | 154 |
3 | CLINICAL BREAST CANCER | 28744 | 2% | 5% | 39 |
4 | BREAST CANCER RESEARCH AND TREATMENT | 25087 | 5% | 2% | 112 |
5 | JOURNAL OF CLINICAL ONCOLOGY | 22579 | 8% | 1% | 159 |
6 | ONCOLOGY | 21834 | 4% | 2% | 77 |
7 | ANTI-CANCER DRUGS | 20511 | 3% | 2% | 68 |
8 | AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 13784 | 3% | 2% | 62 |
9 | CANCER CHEMOTHERAPY AND PHARMACOLOGY | 13546 | 4% | 1% | 83 |
10 | ONCOLOGY-NEW YORK | 12768 | 2% | 2% | 36 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | METASTATIC BREAST CANCER | 2001400 | 22% | 30% | 467 | Search METASTATIC+BREAST+CANCER | Search METASTATIC+BREAST+CANCER |
2 | VINORELBINE | 636753 | 10% | 22% | 203 | Search VINORELBINE | Search VINORELBINE |
3 | DOCETAXEL | 425526 | 15% | 9% | 322 | Search DOCETAXEL | Search DOCETAXEL |
4 | CAPECITABINE | 394666 | 10% | 13% | 203 | Search CAPECITABINE | Search CAPECITABINE |
5 | ADVANCED BREAST CANCER | 300808 | 5% | 22% | 96 | Search ADVANCED+BREAST+CANCER | Search ADVANCED+BREAST+CANCER |
6 | ANTHRACYCLINE RESISTANCE | 154278 | 1% | 56% | 19 | Search ANTHRACYCLINE+RESISTANCE | Search ANTHRACYCLINE+RESISTANCE |
7 | PACLITAXEL | 114974 | 10% | 4% | 220 | Search PACLITAXEL | Search PACLITAXEL |
8 | EPIRUBICIN | 107495 | 4% | 9% | 83 | Search EPIRUBICIN | Search EPIRUBICIN |
9 | TAXANES | 104022 | 4% | 8% | 91 | Search TAXANES | Search TAXANES |
10 | ANTHRACYCLINES | 95089 | 5% | 6% | 107 | Search ANTHRACYCLINES | Search ANTHRACYCLINES |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | SHAMSEDDINE, AI , FARHAT, FS , (2011) PLATINUM-BASED COMPOUNDS FOR THE TREATMENT OF METASTATIC BREAST CANCER.CHEMOTHERAPY. VOL. 57. ISSUE 6. P. 468 -487 | 121 | 73% | 21 |
2 | MANO, M , (2006) VINORELBINE IN THE MANAGEMENT OF BREAST CANCER: NEW PERSPECTIVES, REVIVED ROLE IN THE ERA OF TARGETED THERAPY.CANCER TREATMENT REVIEWS. VOL. 32. ISSUE 2. P. 106-118 | 83 | 78% | 49 |
3 | DECATRIS, MP , SUNDAR, S , O'BYRNE, KJ , (2004) PLATINUM-BASED CHEMOTHERAPY IN METASTATIC BREAST CANCER: CURRENT STATUS.CANCER TREATMENT REVIEWS. VOL. 30. ISSUE 1. P. 53-81 | 105 | 55% | 105 |
4 | CHAN, A , VERRILL, M , (2009) CAPECITABINE AND VINORELBINE IN METASTATIC BREAST CANCER.EUROPEAN JOURNAL OF CANCER. VOL. 45. ISSUE 13. P. 2253 -2265 | 56 | 78% | 16 |
5 | DENT, S , MESSERSMITH, H , TRUDEAU, M , (2008) GEMCITABINE IN THE MANAGEMENT OF METASTATIC BREAST CANCER: A SYSTEMATIC REVIEW.BREAST CANCER RESEARCH AND TREATMENT. VOL. 108. ISSUE 3. P. 319 -331 | 43 | 91% | 30 |
6 | YARDLEY, DA , (2010) VISCERAL DISEASE IN PATIENTS WITH METASTATIC BREAST CANCER: EFFICACY AND SAFETY OF TREATMENT WITH IXABEPILONE AND OTHER CHEMOTHERAPEUTIC AGENTS.CLINICAL BREAST CANCER. VOL. 10. ISSUE 1. P. 64-73 | 62 | 60% | 13 |
7 | ESTEVA, FJ , VALERO, V , PUSZTAI, L , BOEHNKE-MICHAUD, L , BUZDAR, AU , HORTOBAGYI, GN , (2001) CHEMOTHERAPY OF METASTATIC BREAST CANCER: WHAT TO EXPECT IN 2001 AND BEYOND.ONCOLOGIST. VOL. 6. ISSUE 2. P. 133 -146 | 54 | 75% | 109 |
8 | NABHOLTZ, JM , GLIGOROV, J , (2005) DOCETAXEL IN THE TREATMENT OF BREAST CANCER: CURRENT EXPERIENCE AND FUTURE PROSPECTS.EXPERT REVIEW OF ANTICANCER THERAPY. VOL. 5. ISSUE 4. P. 613-633 | 66 | 61% | 5 |
9 | ROBERT, NJ , VOGEL, CL , HENDERSON, C , SPARANO, JA , MOORE, MR , SILVERMAN, P , OVERMOYER, BA , SHAPIRO, CL , PARK, JW , COLBERN, GT , ET AL (2004) THE ROLE OF THE LIPOSOMAL ANTHRACYCLINES AND OTHER SYSTEMIC THERAPIES IN THE MANAGEMENT OF ADVANCED BREAST CANCER.SEMINARS IN ONCOLOGY. VOL. 31. ISSUE 6. P. 106 -146 | 85 | 44% | 42 |
10 | LYSENG-WILLIAMSON, KA , FENTON, C , (2005) DOCETAXEL - A REVIEW OF ITS USE IN METASTATIC BREAST CANCER.DRUGS. VOL. 65. ISSUE 17. P. 2513-2531 | 43 | 78% | 93 |
Classes with closest relation at Level 1 |